AKT1 and cancer: The PI3K/Akt pathway activates mTOR by inhibiting tuberous sclerosis complex 1 (TSC1), enhancing protein synthesis and promoting cellular metabolism, growth, and proliferation, thereby regulating cancer cell growth and metastasis (39).